Sign In
Buy RHHBY
$54.64
-0.630 (-1.14%)
At Close: Jul 31, 2026
First Look: Pershing's UMG bid, Fed hawkish signals, GLP‑1 pill momentum
07:37am, Tuesday, 07'th Apr 2026
Stock News Markets edge higher before Iran deadline: Global equities were mixed and oil volatile ahead of President Trump's deadline on Iran's Hormuz reopening,
Market Today: JPM's Dimon warns; UAL hikes fees; NBIX buys SLNO
05:34pm, Monday, 06'th Apr 2026
Stock News JPMorgan CEO flags inflation risks: JPMorgan Chase (JPM) CEO Jamie Dimon warned in his annual letter that the Iran war could spur persistent inflatio
The Zacks Analyst Blog Roche Holding, AT&T and Amgen
05:56am, Tuesday, 31'st Mar 2026
AMGN, T, and Roche shares outperform as strong drug portfolios and wireless momentum offset key headwinds like pricing pressure and legacy declines.
Roche Holding AG (OTCMKTS:RHHBY) Receives $57.00 Average Price Target from Analysts
03:32am, Monday, 30'th Mar 2026
Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have received a consensus rating of "Hold" from the ten analysts that are currently covering the company, MarketBeat.com reports. One equit
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
01:00am, Monday, 30'th Mar 2026
Basel, 30 March 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the cobas® MPX-E assay, a qualitative in-vitro test for the detection and discrimination of Human Immunodeficiency Virus
Vector Institute Extends Collaboration With Roche
10:06am, Friday, 27'th Mar 2026
TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- Today, the Vector Institute announced the renewal of its collaboration with Roche through 2030, extending a connection that has advanced artificial intellig
The new test detects up to 250 viruses and bacteria, including SARS-CoV-2, influenza, Bordetella pertussis , and RSV, in a single patient sample. Rapid results enable doctors to make fast, confident a
Basel, 23 March 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today the inauguration of the new research home for the Institute of Human Biology. The opening marks a significant milestone in Roc
Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says
04:07am, Monday, 23'rd Mar 2026
The company discontinued developing emugrobart after two studies showed the drug didn't achieve intended outcomes.
Roche Bets Splits in Obesity Market Will Open Door to New Entrants
03:27am, Thursday, 19'th Mar 2026
EXCLUSIVE: The pharmaceutical giant is re-entering the obesity market and aims to become a top-three player, rivaling the likes of Eli Lilly and Novo Nordisk.
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)
01:57pm, Wednesday, 18'th Mar 2026
Roche Holding AG has announced a major AI infrastructure expansion with Nvidia, surpassing peers in GPU deployment for drug development. RHHBY now operates over 3,500 Blackwell GPUs, positioning itsel
Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
09:00am, Wednesday, 18'th Mar 2026
Roche's Ionify® steroid assays join its Vitamin D Total test as the latest mass spectrometry tests to receive CLIA 'moderate complexity' classification. The expanded steroid menu brings the sensitivi
Roche Bought Thousands Of Nvidia AI Chips To Speed Up Drug Development
07:16pm, Monday, 16'th Mar 2026
ByAmy Feldman,
Roche ramps up AI computing capacity with Nvidia chip expansion
04:33pm, Monday, 16'th Mar 2026
Swiss drugmaker Roche said on Monday it had expanded its artificial intelligence computing capacity with more than 2,100 Nvidia chips to support drug and diagnostics development.
